NCT03423121View on ClinicalTrials.gov

A Trial of Bile Acid Supplementation in Patients With Multiple Sclerosis

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

59

Participants

Timeline

Start Date

June 19, 2018

Primary Completion Date

April 28, 2022

Study Completion Date

July 5, 2022

Conditions
Progressive Multiple Sclerosis
Interventions
DRUG

Tauroursodeoxycholic Acid

Participants will be given 1 gram of Tauroursodeoxycholic acid twice daily in the form of four 250mg capsules.

DRUG

Placebo oral capsule

Participants will be given four capsules of the placebo twice daily.

Trial Locations (1)

21287

Johns Hopkins University, Baltimore

All Listed Sponsors
lead

Johns Hopkins University

OTHER

NCT03423121 - A Trial of Bile Acid Supplementation in Patients With Multiple Sclerosis | Biotech Hunter | Biotech Hunter